ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

Group 1 - ANI Pharmaceuticals, Inc. is in the process of completing its acquisition of Alimera Sciences, Inc. and is working in good faith to resolve any delays related to closing conditions [1] - The company emphasizes that any delays are due to discussions regarding closing conditions, which are expected to be resolved promptly [1] - ANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products [2] Group 2 - ANI Pharmaceuticals aims to deliver sustainable growth by scaling up its Rare Disease business, enhancing its Generics business, and leveraging its U.S. based manufacturing capabilities [2]